SCHEMBL13745015

SCHEMBL13745015

CC(C)(C)OC(=O)CN(Cc1ccc(F)cc1)NC(=O)NCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
MAOB P27338 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 2/20 0.42
NR1D1 P20393 1/20 0.42
PPID Q08752 1/20 0.42
HPGD P15428 1/20 0.41
AKT1 P31749 2/20 0.41
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
OPRL1 P41146 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13745661 0.93 PPID (0.47) GAAPPIDAKT1SMN1; SMN2KDM4E
SCHEMBL13745043 0.84 RAB9A (0.55) RAB9ANPC1POLBMAOBALDH1A1
SCHEMBL23804464 0.80 PPID (0.43) ALDH1A1PPIDAKT1SMN1; SMN2
SCHEMBL13745279 0.79 PPID (0.49) RAB9AALDH1A1PPIDAKT1SMN1; SMN2
SCHEMBL23804493 0.76 HPGD (0.46) RAB9APOLBKMT2APPIDHPGD
SCHEMBL4251703 0.76 AKT1 (0.46) RAB9ANPC1POLBMAOBALDH1A1
SCHEMBL13745028 0.76 EPHX1 (0.49) GAAHPGDSMN1; SMN2LMNAKDM4E
SCHEMBL22649519 0.74 AKT1 (0.54) RAB9AALDH1A1PPIDAKT1SMN1; SMN2
SCHEMBL6988810 0.73 PPID (0.68) RAB9AALDH1A1GAAPPIDSMN1; SMN2
SCHEMBL20911008 0.72 RAB9A (0.75) RAB9ANPC1POLBMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed
WO-2007139346-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 RAB9A 3503/4885NPC1 3375/4885POLB 3512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.